Pregnancy outcomes of women who received conservative therapy for endometrial carcinoma or atypical endometrial hyperplasia

Pregnancy outcomes of women who received conservative therapy for endometrial carcinoma or atypical endometrial hyperplasia

Abstract Case Approximately 3%‐25% of cases of endometrial carcinoma (EC) or atypical endometrial hyperplasia (AH) occur in women aged <40 years and conservative treatment with high‐dose medroxyprogesterone acetate (MPA) is administered to women who wish to preserve their fertility. Here is repor...

Celý popis

Podrobná bibliografie
Hlavní autoři: Toshiya Matsuzaki, Takeshi Iwasa, Takako Kawakita, Yuri Yamamoto, Akiko Abe, Aki Hayashi, Kiyohito Yano, Masato Nishimura, Akira Kuwahara, Minoru Irahara
Médium: Článek
Jazyk:English
Vydáno: Wiley 2018-07-01
Edice:Reproductive Medicine and Biology
Témata:
assisted reproductive technology
atypical endometrial hyperplasia
conservative treatment
endometrial carcinoma
medroxyprogesterone acetate
On-line přístup:https://doi.org/10.1002/rmb2.12209

Internet

https://doi.org/10.1002/rmb2.12209

Podobné jednotky